nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—ABCB1—Vismodegib—skin cancer	0.135	0.21	CbGbCtD
Dihydroergotamine—CYP3A4—Imiquimod—skin cancer	0.116	0.182	CbGbCtD
Dihydroergotamine—CYP3A4—Temozolomide—skin cancer	0.116	0.182	CbGbCtD
Dihydroergotamine—CYP3A4—Vismodegib—skin cancer	0.0806	0.126	CbGbCtD
Dihydroergotamine—ABCB1—Dactinomycin—skin cancer	0.0707	0.11	CbGbCtD
Dihydroergotamine—CYP3A4—Vemurafenib—skin cancer	0.0637	0.0995	CbGbCtD
Dihydroergotamine—ABCB1—Docetaxel—skin cancer	0.0365	0.057	CbGbCtD
Dihydroergotamine—CYP3A4—Docetaxel—skin cancer	0.0219	0.0341	CbGbCtD
Dihydroergotamine—Agitation—Imiquimod—skin cancer	0.00113	0.00313	CcSEcCtD
Dihydroergotamine—Malaise—Imiquimod—skin cancer	0.00111	0.00307	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Bleomycin—skin cancer	0.0011	0.00305	CcSEcCtD
Dihydroergotamine—Hypotension—Vemurafenib—skin cancer	0.0011	0.00305	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Bleomycin—skin cancer	0.00109	0.00304	CcSEcCtD
Dihydroergotamine—Influenza like illness—Docetaxel—skin cancer	0.00109	0.00302	CcSEcCtD
Dihydroergotamine—Palpitations—Imiquimod—skin cancer	0.00108	0.00301	CcSEcCtD
Dihydroergotamine—Muscular weakness—Temozolomide—skin cancer	0.00108	0.00299	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00107	0.00297	CcSEcCtD
Dihydroergotamine—Hypertension—Imiquimod—skin cancer	0.00106	0.00294	CcSEcCtD
Dihydroergotamine—Dysphagia—Temozolomide—skin cancer	0.00105	0.00293	CcSEcCtD
Dihydroergotamine—Arthralgia—Imiquimod—skin cancer	0.00104	0.0029	CcSEcCtD
Dihydroergotamine—Myalgia—Imiquimod—skin cancer	0.00104	0.0029	CcSEcCtD
Dihydroergotamine—Anxiety—Imiquimod—skin cancer	0.00104	0.00289	CcSEcCtD
Dihydroergotamine—Discomfort—Imiquimod—skin cancer	0.00103	0.00287	CcSEcCtD
Dihydroergotamine—Sweating increased—Temozolomide—skin cancer	0.00103	0.00286	CcSEcCtD
Dihydroergotamine—Dry mouth—Imiquimod—skin cancer	0.00102	0.00284	CcSEcCtD
Dihydroergotamine—Decreased appetite—Vemurafenib—skin cancer	0.00102	0.00284	CcSEcCtD
Dihydroergotamine—Bronchitis—Temozolomide—skin cancer	0.00101	0.00282	CcSEcCtD
Dihydroergotamine—Fatigue—Vemurafenib—skin cancer	0.00101	0.00281	CcSEcCtD
Dihydroergotamine—Oedema—Imiquimod—skin cancer	0.001	0.00278	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Bleomycin—skin cancer	0.000995	0.00277	CcSEcCtD
Dihydroergotamine—Muscular weakness—Fluorouracil—skin cancer	0.000991	0.00276	CcSEcCtD
Dihydroergotamine—Shock—Imiquimod—skin cancer	0.000984	0.00274	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Temozolomide—skin cancer	0.00098	0.00272	CcSEcCtD
Dihydroergotamine—Tachycardia—Imiquimod—skin cancer	0.000976	0.00272	CcSEcCtD
Dihydroergotamine—Pollakiuria—Temozolomide—skin cancer	0.000974	0.00271	CcSEcCtD
Dihydroergotamine—Dysphagia—Fluorouracil—skin cancer	0.000971	0.0027	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Imiquimod—skin cancer	0.000967	0.00269	CcSEcCtD
Dihydroergotamine—Anorexia—Imiquimod—skin cancer	0.000953	0.00265	CcSEcCtD
Dihydroergotamine—Angina pectoris—Fluorouracil—skin cancer	0.000946	0.00263	CcSEcCtD
Dihydroergotamine—Flushing—Bleomycin—skin cancer	0.000928	0.00258	CcSEcCtD
Dihydroergotamine—Body temperature increased—Vemurafenib—skin cancer	0.000927	0.00258	CcSEcCtD
Dihydroergotamine—Pharyngitis—Dactinomycin—skin cancer	0.000926	0.00257	CcSEcCtD
Dihydroergotamine—Swelling—Docetaxel—skin cancer	0.000919	0.00256	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000911	0.00253	CcSEcCtD
Dihydroergotamine—Insomnia—Imiquimod—skin cancer	0.000905	0.00252	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000903	0.00251	CcSEcCtD
Dihydroergotamine—Paraesthesia—Imiquimod—skin cancer	0.000898	0.0025	CcSEcCtD
Dihydroergotamine—Chills—Bleomycin—skin cancer	0.000897	0.0025	CcSEcCtD
Dihydroergotamine—Dyspnoea—Imiquimod—skin cancer	0.000892	0.00248	CcSEcCtD
Dihydroergotamine—Somnolence—Imiquimod—skin cancer	0.000889	0.00247	CcSEcCtD
Dihydroergotamine—Sinusitis—Temozolomide—skin cancer	0.000882	0.00245	CcSEcCtD
Dihydroergotamine—Dyspepsia—Imiquimod—skin cancer	0.00088	0.00245	CcSEcCtD
Dihydroergotamine—Decreased appetite—Imiquimod—skin cancer	0.00087	0.00242	CcSEcCtD
Dihydroergotamine—Hot flush—Docetaxel—skin cancer	0.000867	0.00241	CcSEcCtD
Dihydroergotamine—Flushing—Dactinomycin—skin cancer	0.000866	0.00241	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Vemurafenib—skin cancer	0.000864	0.0024	CcSEcCtD
Dihydroergotamine—Fatigue—Imiquimod—skin cancer	0.000862	0.0024	CcSEcCtD
Dihydroergotamine—Menopausal symptoms—Docetaxel—skin cancer	0.00086	0.00239	CcSEcCtD
Dihydroergotamine—Pain—Imiquimod—skin cancer	0.000855	0.00238	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000854	0.00237	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Fluorouracil—skin cancer	0.000849	0.00236	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Fluorouracil—skin cancer	0.000842	0.00234	CcSEcCtD
Dihydroergotamine—Asthenia—Vemurafenib—skin cancer	0.000842	0.00234	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Temozolomide—skin cancer	0.000839	0.00233	CcSEcCtD
Dihydroergotamine—Pharyngitis—Temozolomide—skin cancer	0.000837	0.00233	CcSEcCtD
Dihydroergotamine—Chills—Dactinomycin—skin cancer	0.000837	0.00233	CcSEcCtD
Dihydroergotamine—Pruritus—Vemurafenib—skin cancer	0.00083	0.00231	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Imiquimod—skin cancer	0.000824	0.00229	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Imiquimod—skin cancer	0.000818	0.00227	CcSEcCtD
Dihydroergotamine—Epistaxis—Fluorouracil—skin cancer	0.000817	0.00227	CcSEcCtD
Dihydroergotamine—Visual impairment—Temozolomide—skin cancer	0.000813	0.00226	CcSEcCtD
Dihydroergotamine—Sinusitis—Fluorouracil—skin cancer	0.000812	0.00226	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Bleomycin—skin cancer	0.000808	0.00225	CcSEcCtD
Dihydroergotamine—Diarrhoea—Vemurafenib—skin cancer	0.000803	0.00223	CcSEcCtD
Dihydroergotamine—Migraine—Docetaxel—skin cancer	0.000798	0.00222	CcSEcCtD
Dihydroergotamine—Urticaria—Imiquimod—skin cancer	0.000795	0.00221	CcSEcCtD
Dihydroergotamine—Body temperature increased—Imiquimod—skin cancer	0.000791	0.0022	CcSEcCtD
Dihydroergotamine—Abdominal pain—Imiquimod—skin cancer	0.000791	0.0022	CcSEcCtD
Dihydroergotamine—Tinnitus—Temozolomide—skin cancer	0.000787	0.00219	CcSEcCtD
Dihydroergotamine—Malaise—Bleomycin—skin cancer	0.000785	0.00218	CcSEcCtD
Dihydroergotamine—Flushing—Temozolomide—skin cancer	0.000783	0.00218	CcSEcCtD
Dihydroergotamine—Rhinitis—Fluorouracil—skin cancer	0.000779	0.00217	CcSEcCtD
Dihydroergotamine—Dizziness—Vemurafenib—skin cancer	0.000776	0.00216	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Fluorouracil—skin cancer	0.000773	0.00215	CcSEcCtD
Dihydroergotamine—Pharyngitis—Fluorouracil—skin cancer	0.000772	0.00215	CcSEcCtD
Dihydroergotamine—Chills—Temozolomide—skin cancer	0.000757	0.00211	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dactinomycin—skin cancer	0.000753	0.0021	CcSEcCtD
Dihydroergotamine—Vomiting—Vemurafenib—skin cancer	0.000746	0.00207	CcSEcCtD
Dihydroergotamine—Myalgia—Bleomycin—skin cancer	0.000741	0.00206	CcSEcCtD
Dihydroergotamine—Rash—Vemurafenib—skin cancer	0.00074	0.00206	CcSEcCtD
Dihydroergotamine—Dermatitis—Vemurafenib—skin cancer	0.000739	0.00205	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Imiquimod—skin cancer	0.000737	0.00205	CcSEcCtD
Dihydroergotamine—Headache—Vemurafenib—skin cancer	0.000735	0.00204	CcSEcCtD
Dihydroergotamine—Discomfort—Bleomycin—skin cancer	0.000732	0.00204	CcSEcCtD
Dihydroergotamine—Malaise—Dactinomycin—skin cancer	0.000732	0.00204	CcSEcCtD
Dihydroergotamine—Cramp muscle—Docetaxel—skin cancer	0.00073	0.00203	CcSEcCtD
Dihydroergotamine—Asthenia—Imiquimod—skin cancer	0.000718	0.002	CcSEcCtD
Dihydroergotamine—Confusional state—Bleomycin—skin cancer	0.000717	0.00199	CcSEcCtD
Dihydroergotamine—Oedema—Bleomycin—skin cancer	0.000711	0.00198	CcSEcCtD
Dihydroergotamine—Pruritus—Imiquimod—skin cancer	0.000708	0.00197	CcSEcCtD
Dihydroergotamine—Dysphagia—Docetaxel—skin cancer	0.000701	0.00195	CcSEcCtD
Dihydroergotamine—Nausea—Vemurafenib—skin cancer	0.000697	0.00194	CcSEcCtD
Dihydroergotamine—Myalgia—Dactinomycin—skin cancer	0.000691	0.00192	CcSEcCtD
Dihydroergotamine—Bronchospasm—Docetaxel—skin cancer	0.00069	0.00192	CcSEcCtD
Dihydroergotamine—Tremor—Temozolomide—skin cancer	0.000688	0.00191	CcSEcCtD
Dihydroergotamine—Diarrhoea—Imiquimod—skin cancer	0.000684	0.0019	CcSEcCtD
Dihydroergotamine—Discomfort—Dactinomycin—skin cancer	0.000683	0.0019	CcSEcCtD
Dihydroergotamine—Angina pectoris—Docetaxel—skin cancer	0.000683	0.0019	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Temozolomide—skin cancer	0.000681	0.0019	CcSEcCtD
Dihydroergotamine—Anorexia—Bleomycin—skin cancer	0.000677	0.00188	CcSEcCtD
Dihydroergotamine—Agitation—Temozolomide—skin cancer	0.000675	0.00188	CcSEcCtD
Dihydroergotamine—Hypotension—Bleomycin—skin cancer	0.000664	0.00185	CcSEcCtD
Dihydroergotamine—Oedema—Dactinomycin—skin cancer	0.000663	0.00184	CcSEcCtD
Dihydroergotamine—Malaise—Temozolomide—skin cancer	0.000662	0.00184	CcSEcCtD
Dihydroergotamine—Dizziness—Imiquimod—skin cancer	0.000661	0.00184	CcSEcCtD
Dihydroergotamine—Vertigo—Temozolomide—skin cancer	0.00066	0.00184	CcSEcCtD
Dihydroergotamine—Palpitations—Temozolomide—skin cancer	0.000649	0.00181	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000647	0.0018	CcSEcCtD
Dihydroergotamine—Paraesthesia—Bleomycin—skin cancer	0.000638	0.00177	CcSEcCtD
Dihydroergotamine—Vomiting—Imiquimod—skin cancer	0.000636	0.00177	CcSEcCtD
Dihydroergotamine—Hypertension—Temozolomide—skin cancer	0.000634	0.00176	CcSEcCtD
Dihydroergotamine—Dyspnoea—Bleomycin—skin cancer	0.000634	0.00176	CcSEcCtD
Dihydroergotamine—Anorexia—Dactinomycin—skin cancer	0.000632	0.00176	CcSEcCtD
Dihydroergotamine—Rash—Imiquimod—skin cancer	0.000631	0.00175	CcSEcCtD
Dihydroergotamine—Dermatitis—Imiquimod—skin cancer	0.00063	0.00175	CcSEcCtD
Dihydroergotamine—Headache—Imiquimod—skin cancer	0.000627	0.00174	CcSEcCtD
Dihydroergotamine—Myalgia—Temozolomide—skin cancer	0.000625	0.00174	CcSEcCtD
Dihydroergotamine—Arthralgia—Temozolomide—skin cancer	0.000625	0.00174	CcSEcCtD
Dihydroergotamine—Anxiety—Temozolomide—skin cancer	0.000623	0.00173	CcSEcCtD
Dihydroergotamine—Discomfort—Temozolomide—skin cancer	0.000618	0.00172	CcSEcCtD
Dihydroergotamine—Decreased appetite—Bleomycin—skin cancer	0.000618	0.00172	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Docetaxel—skin cancer	0.000616	0.00171	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Docetaxel—skin cancer	0.000613	0.0017	CcSEcCtD
Dihydroergotamine—Dry mouth—Temozolomide—skin cancer	0.000612	0.0017	CcSEcCtD
Dihydroergotamine—Pain—Bleomycin—skin cancer	0.000608	0.00169	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Docetaxel—skin cancer	0.000608	0.00169	CcSEcCtD
Dihydroergotamine—Confusional state—Temozolomide—skin cancer	0.000604	0.00168	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000604	0.00168	CcSEcCtD
Dihydroergotamine—Oedema—Temozolomide—skin cancer	0.000599	0.00167	CcSEcCtD
Dihydroergotamine—Nausea—Imiquimod—skin cancer	0.000594	0.00165	CcSEcCtD
Dihydroergotamine—Epistaxis—Docetaxel—skin cancer	0.00059	0.00164	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Bleomycin—skin cancer	0.000586	0.00163	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Temozolomide—skin cancer	0.000579	0.00161	CcSEcCtD
Dihydroergotamine—Myalgia—Fluorouracil—skin cancer	0.000576	0.0016	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dactinomycin—skin cancer	0.000576	0.0016	CcSEcCtD
Dihydroergotamine—Fatigue—Dactinomycin—skin cancer	0.000571	0.00159	CcSEcCtD
Dihydroergotamine—Anorexia—Temozolomide—skin cancer	0.000571	0.00159	CcSEcCtD
Dihydroergotamine—Discomfort—Fluorouracil—skin cancer	0.000569	0.00158	CcSEcCtD
Dihydroergotamine—Pain—Dactinomycin—skin cancer	0.000567	0.00158	CcSEcCtD
Dihydroergotamine—Urticaria—Bleomycin—skin cancer	0.000565	0.00157	CcSEcCtD
Dihydroergotamine—Rhinitis—Docetaxel—skin cancer	0.000563	0.00156	CcSEcCtD
Dihydroergotamine—Body temperature increased—Bleomycin—skin cancer	0.000562	0.00156	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Docetaxel—skin cancer	0.000558	0.00155	CcSEcCtD
Dihydroergotamine—Confusional state—Fluorouracil—skin cancer	0.000557	0.00155	CcSEcCtD
Dihydroergotamine—Pharyngitis—Docetaxel—skin cancer	0.000557	0.00155	CcSEcCtD
Dihydroergotamine—Oedema—Fluorouracil—skin cancer	0.000552	0.00154	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dactinomycin—skin cancer	0.000546	0.00152	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000546	0.00152	CcSEcCtD
Dihydroergotamine—Insomnia—Temozolomide—skin cancer	0.000542	0.00151	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000542	0.00151	CcSEcCtD
Dihydroergotamine—Visual impairment—Docetaxel—skin cancer	0.000541	0.0015	CcSEcCtD
Dihydroergotamine—Tachycardia—Fluorouracil—skin cancer	0.000539	0.0015	CcSEcCtD
Dihydroergotamine—Paraesthesia—Temozolomide—skin cancer	0.000538	0.0015	CcSEcCtD
Dihydroergotamine—Dyspnoea—Temozolomide—skin cancer	0.000534	0.00149	CcSEcCtD
Dihydroergotamine—Somnolence—Temozolomide—skin cancer	0.000533	0.00148	CcSEcCtD
Dihydroergotamine—Dyspepsia—Temozolomide—skin cancer	0.000528	0.00147	CcSEcCtD
Dihydroergotamine—Anorexia—Fluorouracil—skin cancer	0.000526	0.00146	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dactinomycin—skin cancer	0.000524	0.00146	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dactinomycin—skin cancer	0.000524	0.00146	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Bleomycin—skin cancer	0.000524	0.00146	CcSEcCtD
Dihydroergotamine—Decreased appetite—Temozolomide—skin cancer	0.000521	0.00145	CcSEcCtD
Dihydroergotamine—Flushing—Docetaxel—skin cancer	0.000521	0.00145	CcSEcCtD
Dihydroergotamine—Fatigue—Temozolomide—skin cancer	0.000517	0.00144	CcSEcCtD
Dihydroergotamine—Hypotension—Fluorouracil—skin cancer	0.000516	0.00144	CcSEcCtD
Dihydroergotamine—Pain—Temozolomide—skin cancer	0.000513	0.00143	CcSEcCtD
Dihydroergotamine—Asthenia—Bleomycin—skin cancer	0.00051	0.00142	CcSEcCtD
Dihydroergotamine—Chills—Docetaxel—skin cancer	0.000503	0.0014	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000503	0.0014	CcSEcCtD
Dihydroergotamine—Pruritus—Bleomycin—skin cancer	0.000503	0.0014	CcSEcCtD
Dihydroergotamine—Insomnia—Fluorouracil—skin cancer	0.0005	0.00139	CcSEcCtD
Dihydroergotamine—Paraesthesia—Fluorouracil—skin cancer	0.000496	0.00138	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Temozolomide—skin cancer	0.000494	0.00137	CcSEcCtD
Dihydroergotamine—Dyspnoea—Fluorouracil—skin cancer	0.000492	0.00137	CcSEcCtD
Dihydroergotamine—Somnolence—Fluorouracil—skin cancer	0.000491	0.00137	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Temozolomide—skin cancer	0.00049	0.00136	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Dactinomycin—skin cancer	0.000488	0.00136	CcSEcCtD
Dihydroergotamine—Dyspepsia—Fluorouracil—skin cancer	0.000486	0.00135	CcSEcCtD
Dihydroergotamine—Decreased appetite—Fluorouracil—skin cancer	0.00048	0.00134	CcSEcCtD
Dihydroergotamine—Urticaria—Temozolomide—skin cancer	0.000476	0.00132	CcSEcCtD
Dihydroergotamine—Asthenia—Dactinomycin—skin cancer	0.000476	0.00132	CcSEcCtD
Dihydroergotamine—Body temperature increased—Temozolomide—skin cancer	0.000474	0.00132	CcSEcCtD
Dihydroergotamine—Abdominal pain—Temozolomide—skin cancer	0.000474	0.00132	CcSEcCtD
Dihydroergotamine—Pain—Fluorouracil—skin cancer	0.000472	0.00131	CcSEcCtD
Dihydroergotamine—Muscle spasms—Docetaxel—skin cancer	0.00047	0.00131	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Fluorouracil—skin cancer	0.000455	0.00127	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dactinomycin—skin cancer	0.000453	0.00126	CcSEcCtD
Dihydroergotamine—Vomiting—Bleomycin—skin cancer	0.000452	0.00126	CcSEcCtD
Dihydroergotamine—Rash—Bleomycin—skin cancer	0.000448	0.00125	CcSEcCtD
Dihydroergotamine—Dermatitis—Bleomycin—skin cancer	0.000448	0.00124	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Temozolomide—skin cancer	0.000442	0.00123	CcSEcCtD
Dihydroergotamine—Urticaria—Fluorouracil—skin cancer	0.000439	0.00122	CcSEcCtD
Dihydroergotamine—Body temperature increased—Fluorouracil—skin cancer	0.000437	0.00121	CcSEcCtD
Dihydroergotamine—Palpitations—Docetaxel—skin cancer	0.000432	0.0012	CcSEcCtD
Dihydroergotamine—Asthenia—Temozolomide—skin cancer	0.00043	0.0012	CcSEcCtD
Dihydroergotamine—Pruritus—Temozolomide—skin cancer	0.000424	0.00118	CcSEcCtD
Dihydroergotamine—Nausea—Bleomycin—skin cancer	0.000422	0.00117	CcSEcCtD
Dihydroergotamine—Hypertension—Docetaxel—skin cancer	0.000422	0.00117	CcSEcCtD
Dihydroergotamine—Vomiting—Dactinomycin—skin cancer	0.000421	0.00117	CcSEcCtD
Dihydroergotamine—Rash—Dactinomycin—skin cancer	0.000418	0.00116	CcSEcCtD
Dihydroergotamine—Myalgia—Docetaxel—skin cancer	0.000416	0.00116	CcSEcCtD
Dihydroergotamine—Arthralgia—Docetaxel—skin cancer	0.000416	0.00116	CcSEcCtD
Dihydroergotamine—Diarrhoea—Temozolomide—skin cancer	0.00041	0.00114	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Fluorouracil—skin cancer	0.000407	0.00113	CcSEcCtD
Dihydroergotamine—Dry mouth—Docetaxel—skin cancer	0.000407	0.00113	CcSEcCtD
Dihydroergotamine—Confusional state—Docetaxel—skin cancer	0.000402	0.00112	CcSEcCtD
Dihydroergotamine—Oedema—Docetaxel—skin cancer	0.000399	0.00111	CcSEcCtD
Dihydroergotamine—Dizziness—Temozolomide—skin cancer	0.000396	0.0011	CcSEcCtD
Dihydroergotamine—Nausea—Dactinomycin—skin cancer	0.000394	0.00109	CcSEcCtD
Dihydroergotamine—Shock—Docetaxel—skin cancer	0.000392	0.00109	CcSEcCtD
Dihydroergotamine—Pruritus—Fluorouracil—skin cancer	0.000391	0.00109	CcSEcCtD
Dihydroergotamine—Tachycardia—Docetaxel—skin cancer	0.000389	0.00108	CcSEcCtD
Dihydroergotamine—Vomiting—Temozolomide—skin cancer	0.000381	0.00106	CcSEcCtD
Dihydroergotamine—Anorexia—Docetaxel—skin cancer	0.00038	0.00106	CcSEcCtD
Dihydroergotamine—Rash—Temozolomide—skin cancer	0.000378	0.00105	CcSEcCtD
Dihydroergotamine—Diarrhoea—Fluorouracil—skin cancer	0.000378	0.00105	CcSEcCtD
Dihydroergotamine—Dermatitis—Temozolomide—skin cancer	0.000378	0.00105	CcSEcCtD
Dihydroergotamine—Headache—Temozolomide—skin cancer	0.000376	0.00104	CcSEcCtD
Dihydroergotamine—Hypotension—Docetaxel—skin cancer	0.000372	0.00104	CcSEcCtD
Dihydroergotamine—Dizziness—Fluorouracil—skin cancer	0.000365	0.00102	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000363	0.00101	CcSEcCtD
Dihydroergotamine—Insomnia—Docetaxel—skin cancer	0.000361	0.001	CcSEcCtD
Dihydroergotamine—Paraesthesia—Docetaxel—skin cancer	0.000358	0.000996	CcSEcCtD
Dihydroergotamine—Nausea—Temozolomide—skin cancer	0.000356	0.00099	CcSEcCtD
Dihydroergotamine—Dyspnoea—Docetaxel—skin cancer	0.000355	0.000988	CcSEcCtD
Dihydroergotamine—Somnolence—Docetaxel—skin cancer	0.000354	0.000986	CcSEcCtD
Dihydroergotamine—Vomiting—Fluorouracil—skin cancer	0.000351	0.000977	CcSEcCtD
Dihydroergotamine—Dyspepsia—Docetaxel—skin cancer	0.000351	0.000976	CcSEcCtD
Dihydroergotamine—Rash—Fluorouracil—skin cancer	0.000348	0.000968	CcSEcCtD
Dihydroergotamine—Dermatitis—Fluorouracil—skin cancer	0.000348	0.000968	CcSEcCtD
Dihydroergotamine—Decreased appetite—Docetaxel—skin cancer	0.000347	0.000964	CcSEcCtD
Dihydroergotamine—Headache—Fluorouracil—skin cancer	0.000346	0.000962	CcSEcCtD
Dihydroergotamine—Fatigue—Docetaxel—skin cancer	0.000344	0.000956	CcSEcCtD
Dihydroergotamine—Pain—Docetaxel—skin cancer	0.000341	0.000948	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Docetaxel—skin cancer	0.000328	0.000914	CcSEcCtD
Dihydroergotamine—Nausea—Fluorouracil—skin cancer	0.000328	0.000912	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Docetaxel—skin cancer	0.000326	0.000907	CcSEcCtD
Dihydroergotamine—Abdominal pain—Docetaxel—skin cancer	0.000315	0.000876	CcSEcCtD
Dihydroergotamine—Body temperature increased—Docetaxel—skin cancer	0.000315	0.000876	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Docetaxel—skin cancer	0.000294	0.000817	CcSEcCtD
Dihydroergotamine—Asthenia—Docetaxel—skin cancer	0.000286	0.000795	CcSEcCtD
Dihydroergotamine—Pruritus—Docetaxel—skin cancer	0.000282	0.000784	CcSEcCtD
Dihydroergotamine—Diarrhoea—Docetaxel—skin cancer	0.000273	0.000759	CcSEcCtD
Dihydroergotamine—Dizziness—Docetaxel—skin cancer	0.000264	0.000733	CcSEcCtD
Dihydroergotamine—Vomiting—Docetaxel—skin cancer	0.000253	0.000705	CcSEcCtD
Dihydroergotamine—Rash—Docetaxel—skin cancer	0.000251	0.000699	CcSEcCtD
Dihydroergotamine—Dermatitis—Docetaxel—skin cancer	0.000251	0.000698	CcSEcCtD
Dihydroergotamine—Headache—Docetaxel—skin cancer	0.00025	0.000695	CcSEcCtD
Dihydroergotamine—Nausea—Docetaxel—skin cancer	0.000237	0.000659	CcSEcCtD
